Mirum

Mirum is a U.S.-based biopharmaceutical company focused on rare disease medicines. It commercializes approved therapies including LIVMARLI, CHOLBAM, and CTEXLI, and also develops a clinical pipeline for additional rare-disease indications.

Relationship details are part of the Pro plan.